Mesoblast surges on FDA nod for its cell therapy
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per cent after
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per cent after
FEATURED
Cohousing trend continues to increase its sway over ageing boomers
Later-life divorces rise as many silver splitter women end up happier
Multigenerational housing to be incorporated into Docks site
ArtPlayer enhances elderly well-being through digital signage in care homes
Green light for grey start-ups bolsters entrepreneurial ranks
Boomers high-rise set to come with a health hub
INNOVATION
